These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 16625553)

  • 1. Buprenorphine for the management of opioid withdrawal.
    Gowing L; Ali R; White J
    Cochrane Database Syst Rev; 2006 Apr; (2):CD002025. PubMed ID: 16625553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buprenorphine for the management of opioid withdrawal.
    Gowing L; Ali R; White JM
    Cochrane Database Syst Rev; 2009 Jul; (3):CD002025. PubMed ID: 19588330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine for the management of opioid withdrawal.
    Gowing L; Ali R; White J
    Cochrane Database Syst Rev; 2004 Oct; (4):CD002025. PubMed ID: 15495026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine for managing opioid withdrawal.
    Gowing L; Ali R; White JM; Mbewe D
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD002025. PubMed ID: 28220474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha2-adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell MF; Ali R; White JM
    Cochrane Database Syst Rev; 2014 Mar; (3):CD002024. PubMed ID: 24683051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha2-adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell M; Ali R; White JM
    Cochrane Database Syst Rev; 2009 Apr; (2):CD002024. PubMed ID: 19370574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alphaâ‚‚-adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell M; Ali R; White JM
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD002024. PubMed ID: 27140827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine for the management of opioid withdrawal.
    Gowing L; Ali R; White J
    Cochrane Database Syst Rev; 2000; (3):CD002025. PubMed ID: 10908521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buprenorphine for the management of opioid withdrawal.
    Gowing L; Ali R; White J
    Cochrane Database Syst Rev; 2002; (2):CD002025. PubMed ID: 12076434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha2 adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell M; Ali R; White J
    Cochrane Database Syst Rev; 2004 Oct; (4):CD002024. PubMed ID: 15495025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha2 adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell M; Ali R; White J
    Cochrane Database Syst Rev; 2003; (2):CD002024. PubMed ID: 12804419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid antagonists with minimal sedation for opioid withdrawal.
    Gowing L; Ali R; White JM
    Cochrane Database Syst Rev; 2017 May; 5(5):CD002021. PubMed ID: 28553701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological therapies for management of opium withdrawal.
    Rahimi-Movaghar A; Gholami J; Amato L; Hoseinie L; Yousefi-Nooraie R; Amin-Esmaeili M
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD007522. PubMed ID: 29929212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid antagonists with minimal sedation for opioid withdrawal.
    Gowing L; Ali R; White J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD002021. PubMed ID: 16437438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid antagonists with minimal sedation for opioid withdrawal.
    Gowing L; Ali R; White JM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD002021. PubMed ID: 19821290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal.
    Gowing L; Ali R; White J
    Cochrane Database Syst Rev; 2006 Apr; (2):CD002022. PubMed ID: 16625552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha2 adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell M; Ali R; White J
    Cochrane Database Syst Rev; 2001; (1):CD002024. PubMed ID: 11279747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal.
    Gowing L; Ali R; White JM
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD002022. PubMed ID: 20091529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Breen C; Kimber J; Davoli M
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD002207. PubMed ID: 24500948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid antagonists and adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Ali R; White J
    Cochrane Database Syst Rev; 2000; (2):CD002021. PubMed ID: 10796843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.